Analyst Research

Report Title Price
Provider: Reuters Investment Profile
Provider: Thomson Reuters Stock Report
Provider: Ford Investor Services, Inc.
Provider: ValuEngine, Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Agios Pharmaceuticals Inc Closes Initial Public Offering

Monday, 29 Jul 2013 05:00pm EDT 

Agios Pharmaceuticals Inc announced that the closing of its initial public offering of 6,772,221 shares of its common stock at a public offering price of $18.00 per share, before underwriting discounts, including 883,333 shares of common stock issued upon the exercise in full by the underwriters of their option to purchase additional shares at the public offering price, less the underwriting discount. J.P. Morgan and Goldman, Sachs & Co. acted as joint book-running managers for the offering. Cowen and Company and Leerink Swan acted as co-managers. 

Company Quote

1.17 +0.96%
23 Jan 2015